Register NOW for the FREE Patient and Family Seminar in Philadelphia, PA.
The International Myeloma Foundation (IMF) is excited to announce that the 2025 Philadelphia Patient and Family Seminar will take place on May 2-3, 2025, in Philadelphia, Pennsylvania. The seminar is FREE but in-person seating is LIMITED.
Date and Location:
May 2-3, 2025
DoubleTree by Hilton Philadelphia Center City
237 South Broad Street
Philadelphia, PA 19107
Stay Tuned! Keynote Speaker and Additional Speakers Have Yet to be Announced!
Yelak Biru
IMF President and CEO; 28-Year Myeloma Patient
Sylvia Dsouza
IMF VP of Development
Teresa Miceli RN, BSN, OCN
IMF InfoLine Coordinator
Joseph Mikhael, MD
IMF Chief Medical Officer
Robin Tuohy
IMF VP of Patient Support
Michael Tuohy
24-Year Myeloma Survivor
When you attend a Patient and Family Seminar, you:
- Learn more about new treatment options in the pipeline as well as the latest clinical trials.
- Ask questions face-to-face with world-renowned experts in myeloma
- Share your experiences and gain strength from hearing other people's stories
- Become a part of the IMF family
In-person seating is limited; register today before slots run out. For more detailed information, please visit our registration page.
a
Image Left
White
The 2025 Philadelphia Patient and Family Seminar will cover a variety of topics including:
- Hot Topics in Myeloma
- Patient Empowerment: Shared Decision Making
- Myeloma 101: The Big Picture Perspective with Q&A
- Financial Considerations in Myeloma
- Emotional and Physical Well-Being – Living with a Myeloma Diagnosis
- Understanding Clinical Trials & Patient/Care Partner Testimonial
- Living (with Myeloma): Patient, President & CEO Address
- Fireside Chat: What is the Future of Myeloma? (with Q&A)
- Treatment Approaches in Myeloma
- Partnering with the IMF
- Symptom Management and Living Well with Myeloma
- Closing the Gap: Health Disparities in Myeloma
- “He Said, She Said”: Debates in Myeloma
- Treating Smoldering Myeloma
- Cellular Therapies
- Sequencing Therapies
- Minimal Residual Disease (MRD)
- Myeloma Control or Cure
- Ask the Experts: Q&A with Guest Faculty